文献速递妇产影像介入MRUS

磁共振引导高强度聚焦超声消融子宫肌瘤的疗效、效率与安全性:与超声引导方法的比较

Efficacy, Efficiency, and Safety of Magnetic Resonance-Guided High-Intensity Focused Ultrasound for Ablation of Uterine Fibroids: Comparison with Ultrasound-Guided Method.
PubMed 文献 · Korean J Radiol · 2018-06-14

本研究比较磁共振引导高强度聚焦超声(MRgHIFU)与超声引导高强度聚焦超声(USgHIFU)消融子宫肌瘤的疗效、声能效率、治疗时间和安全性。MRgHIFU组43例44个肌瘤,USgHIFU组51例68个肌瘤,完全消融定义为肌瘤100%无灌注体积。结果显示两组安全性好、能量效率相当,USgHIFU治疗时间更短。

要点

  • 完全消融率:MRgHIFU组23.3%(10/43例),USgHIFU组43.1%(22/51例)。
  • 完全消融肌瘤的能量效率因子:MRgHIFU组5.1±3.0 J/mm³,USgHIFU组4.7±2.5 J/mm³(p=0.165)。
  • 平均治疗时间:MRgHIFU组174.5±42.2分钟,USgHIFU组114.4±39.2分钟(p=0.021)。

核心结论

  • MRgHIFU与USgHIFU对子宫肌瘤完全消融均安全有效,能量效率相当。
  • USgHIFU治疗时间较MRgHIFU短。

研究设计与样本

  • 比较MRgHIFU与USgHIFU消融症状性子宫肌瘤的研究。
  • MRgHIFU组43例患者44个肌瘤,USgHIFU组51例患者68个肌瘤。
  • 治疗后行增强MRI,完全消融定义为肌瘤100%无灌注体积。
  • 选取完全消融的肌瘤比较两组治疗数据和声能参数。

关键影像表现/征象

  • 完全消融:MRgHIFU组10例患者共13个肌瘤(23.3%,10/43),USgHIFU组22例患者共28个肌瘤(43.1%,22/51)。
  • 完全消融肌瘤中,能量效率因子MRgHIFU组5.1±3.0 J/mm³,USgHIFU组4.7±2.5 J/mm³(p=0.165)。
  • 能量效率因子与肌瘤无灌注体积呈负线性相关:MRgHIFU组p=0.016,USgHIFU组p=0.001。
  • 平均治疗时间MRgHIFU组174.5±42.2分钟,USgHIFU组114.4±39.2分钟(p=0.021)。
  • 治疗后无严重不良事件和主要并发症。

诊断标准与关键数值

  • 完全消融定义为增强MRI上肌瘤100%无灌注体积。
  • 完全消融率:MRgHIFU组23.3%(10/43例),USgHIFU组43.1%(22/51例)。
  • 能量效率因子:MRgHIFU组5.1±3.0 J/mm³,USgHIFU组4.7±2.5 J/mm³(p=0.165)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to compare efficacy, sonication energy efficiency, treatment time and safety of magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) and those of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for ablation of uterine fibroids.

MATERIALS AND METHODS: This study included 43 patients with 44 symptomatic uterine fibroids treated with MRgHIFU and 51 patients with 68 symptomatic uterine fibroids treated with USgHIFU. After therapy, contrast-enhanced MRI was conducted and complete ablation was defined as 100% non-perfused volume (NPV) of fibroids. Patients with completely ablated fibroids were selected for the comparison of the treatment data and sonication parameters between MRgHIFU and USgHIFU treated groups.

RESULTS: Thirteen completely ablated fibroids in 10 patients (23.3%, 10/43) were achieved with MRgHIFU and 28 completely ablated fibroids in 22 patients (43.1%, 22/51) were achieved with USgHIFU. In completely ablated fibroids, the energy-efficiency factor (EEF) was 5.1 ± 3.0 J/mm3 and 4.7 ± 2.5 J/mm3 in the MRgHIFU and USgHIFU, respectively (p = 0.165). There was a negative linear correlation between EEF and the NPV of fibroids for MRgHIFU (p = 0.016) and USgHIFU (p = 0.001). The mean treatment time was 174.5 ± 42.2 minutes and 114.4 ± 39.2 minutes in the MRgHIFU and USgHIFU procedures, respectively (p = 0.021). There were no severe adverse events and major complications after treatment.

CONCLUSION: MRgHIFU and USgHIFU are safe and effective with the equivalent energy efficiency for complete ablation of fibroids. USgHIFU has shorter treatment time than MRgHIFU.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Wang Y, Wang ZB, Xu YH, et al. Efficacy, Efficiency, and Safety of Magnetic Resonance-Guided High-Intensity Focused Ultrasound for Ablation of Uterine Fibroids: Comparison with Ultrasound-Guided Method. Korean J Radiol. 2018. PMID: 29962878. doi:10.3348/kjr.2018.19.4.724

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。